Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
SunCoke Energy
SXC
$788M
| $31.6M | 0.02% |
5,067,900
+235,100
| +5% | +$1.31M |
|
|
SOHU
752
Sohu.com
SOHU
$364M
| $31.6M | 0.02% |
2,823,698
+309,398
| +12% | +$3.24M |
|
|
WMC
753
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $31.5M | 0.02% |
304,515
-11,650
| -4% | -$1.18M |
|
|
EMBJ
754
Embraer S.A. ADS
EMBJ
$13.2B
| $31.3M | 0.02% |
1,607,973
+318,450
| +25% | +$5.6M |
|
755
Teekay Tankers
TNK
$2.9B
| $31.3M | 0.02% |
1,305,465
+352,722
| +37% | +$6.42M |
|
756
Acadia Pharmaceuticals
ACAD
$4.89B
| $31.3M | 0.02% |
731,000
+645,200
| +752% | +$28.1M |
|
757
Amkor Technology
AMKR
$14.3B
| $31.1M | 0.02% |
2,394,700
+31,300
| +1% | +$373K |
|
|
CXP
758
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $31.1M | 0.02% |
1,486,100
-84,800
| -5% | -$1.74M |
|
759
Fortuna Silver Mines
FSM
$3.1B
| $31.1M | 0.02% |
7,616,031
-517,234
| -6% | -$1.69M |
|
760
Semtech
SMTC
$12.4B
| $31M | 0.02% |
585,316
-93,384
| -14% | -$4.68M |
|
|
LSXMK
761
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $30.9M | 0.02% |
843,599
+776,901
| +1,165% | +$27.1M |
|
|
PXD
762
DELISTED
Pioneer Natural Resource Co.
PXD
| $30.9M | 0.02% |
204,188
+86,700
| +74% | +$11.5M |
|
|
HBI
763
DELISTED
Hanesbrands
HBI
| $30.9M | 0.02% |
+2,078,900
| New | +$31.6M |
|
764
Leidos
LDOS
$17.9B
| $30.9M | 0.02% |
+315,350
| New | +$27.8M |
|
765
McGrath RentCorp
MGRC
$2.94B
| $30.8M | 0.02% |
401,900
-130,395
| -24% | -$9.46M |
|
766
Advanced Drainage Systems
WMS
$11.3B
| $30.7M | 0.02% |
791,637
+574,437
| +264% | +$21.3M |
|
767
Avient
AVNT
$4.23B
| $30.7M | 0.02% |
835,258
+140,000
| +20% | +$4.57M |
|
768
Gibraltar Industries
ROCK
$1.45B
| $30.7M | 0.02% |
608,004
+234,600
| +63% | +$11.8M |
|
769
Piper Sandler
PIPR
$5.54B
| $30.4M | 0.02% |
1,523,580
-236,420
| -13% | -$4.58M |
|
|
PMT
770
PennyMac Mortgage Investment
PMT
$828M
| $30.4M | 0.02% |
1,365,407
+616,207
| +82% | +$13.9M |
|
|
CCXI
771
DELISTED
ChemoCentryx, Inc.
CCXI
| $30.4M | 0.02% |
768,581
-527,398
| -41% | -$9.26M |
|
772
Anika Therapeutics
ANIK
$283M
| $30.3M | 0.02% |
585,129
+102,207
| +21% | +$5.94M |
|
773
Reliance Steel & Aluminium
RS
$21.7B
| $30.3M | 0.02% |
252,912
-115,700
| -31% | -$13.1M |
|
774
Atlanta Braves Holdings Series B
BATRK
$3.41B
| $30.3M | 0.02% |
1,024,219
-86,900
| -8% | -$2.47M |
|
775
Zebra Technologies
ZBRA
$18B
| $30.3M | 0.02% |
+118,431
| New | +$27.7M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.